Town Square

Stanford begins clinical trials to expand Pfizer vaccine access to young children

Original post made on Apr 16, 2021

Stanford Health Care has begun laying the clinical groundwork to expand COVID-19 vaccine eligibility to the country's youngest children, joining in a nationwide trial to see how safe the Pfizer vaccine is for people ages 2 to 5.

Read the full story here Web Link posted Friday, April 16, 2021, 9:15 AM

Comments (3)

Posted by Jeanne
a resident of another community
on Apr 19, 2021 at 11:01 pm
Jeanne is a registered user.

I am afraid we will look back at this time as the peak of barbarism in human history.

Report Objectionable Content

Email Town Square Moderator

Posted by Rebecca Eisenberg
a resident of Old Palo Alto
on Apr 20, 2021 at 10:29 pm
Rebecca Eisenberg is a registered user.

I am afraid that there will be no people alive to look back at this period in time.

Accordingly, I am grateful that our new federal administration is taking the coronavirus seriously and doing what it can (given our broken health care system) to protect people of all ages, ethnicities, and income levels, so that future generations have the capacity to be more prepared to meet the next challenges more effectively in the future. And so that we have a future!

Report Objectionable Content

Email Town Square Moderator

Posted by Jeanne
a resident of another community
on Apr 21, 2021 at 11:14 am
Jeanne is a registered user.

[Post removed.]

Report Objectionable Content

Email Town Square Moderator

Don't miss out on the discussion!
Sign up to be notified of new comments on this topic.

Town Square

Stanford begins clinical trials to expand Pfizer vaccine access to young children

Stay informed.

Index